0000912061-19-000080.txt : 20191101 0000912061-19-000080.hdr.sgml : 20191101 20191101090836 ACCESSION NUMBER: 0000912061-19-000080 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20191101 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20191101 DATE AS OF CHANGE: 20191101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATURAL HEALTH TRENDS CORP CENTRAL INDEX KEY: 0000912061 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190] IRS NUMBER: 592705336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36849 FILM NUMBER: 191185343 BUSINESS ADDRESS: STREET 1: UNITS 1205-07, 12F, MIRA PLACE TOWER A STREET 2: 132 NATHAN ROAD, TSIMSHATSUI, KOWLOON CITY: HONG KONG STATE: K3 ZIP: 00000 BUSINESS PHONE: 852-3107-0800 MAIL ADDRESS: STREET 1: UNITS 1205-07, 12F, MIRA PLACE TOWER A STREET 2: 132 NATHAN ROAD, TSIMSHATSUI, KOWLOON CITY: HONG KONG STATE: K3 ZIP: 00000 8-K 1 nhtc20191101_8k.htm 8-K Document
false0000912061 0000912061 2019-11-01 2019-11-01


UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
 
November 1, 2019
 
Date of Report (Date of earliest event reported)
 
 NATURAL HEALTH TRENDS CORP.
(Exact name of registrant as specified in its charter)
Delaware
001-36849
59-2705336
(State or other jurisdiction of incorporation)        
(Commission File Number)  
(IRS Employer Identification No.)
 
 
 

 Units 1205-07, 12F, Mira Place Tower A, 132 Nathan Road, Tsimshatsui, Kowloon, Hong Kong
(Address of principal executive offices, including zip code)

+852-3107-0800
(Registrant’s telephone number, including area code)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
NHTC
The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

   Emerging growth company

o   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.







Item 2.02 Results of Operations and Financial Condition.
 
On November 1, 2019, Natural Health Trends Corp. issued an earnings release announcing its results for the quarter ended September 30, 2019. The press release is attached hereto as exhibit 99.1.
 
Item 9.01 Financial Statements and Exhibits.
 
(d)
Exhibits.
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: November 1, 2019
 
NATURAL HEALTH TRENDS CORP.
 
 
 
 
 
 
 
By:
/s/ Timothy S. Davidson                                                     
 
 
Timothy S. Davidson
 
 
Senior Vice President and Chief Financial Officer



EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit
Exhibit 99.1

Natural Health Trends Reports Third Quarter 2019 Financial Results

Repurchased $2.9 million of common stock
Declared a special dividend of $0.40 per share

HONG KONG – November 1, 2019 – Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the third quarter ended September 30, 2019.

Third Quarter 2019 Financial Highlights

Revenue of $17.0 million decreased 64% compared to $47.0 million in the third quarter of 2018.
Gross profit was $12.7 million compared to $37.1 million in the third quarter of 2018. As a percent of total revenue, gross profit was 74% compared to 79% in the third quarter of 2018.
Operating loss was $1.1 million compared to operating income of $7.8 million in the third quarter of 2018.
Net loss was $1.2 million, or $0.12 per diluted share, compared to net income of $7.6 million, or $0.67 per diluted share, in the third quarter of 2018.
The number of Active Members1 decreased 13% to 68,150 at September 30, 2019, compared to 78,280 at June 30, 2019, and decreased 30% compared to 97,160 at September 30, 2018.
1 
Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period.

Year-to-Date 2019 Financial Highlights

Revenue of $59.8 million decreased 60% compared to $150.3 million in the first nine months of 2018.
Gross profit was $44.8 million compared to $119.8 million in the first nine months of 2018. As a percent of total revenue, gross profit was 75% compared to 80% in the first nine months of 2018.
Operating loss was $3.8 million compared to operating income of $28.0 million in the first nine months of 2018.
Net loss was $2.8 million, or $0.25 per diluted share, compared to net income of $25.5 million, or $2.25 per diluted share, in the first nine months of 2018.


1



Management Commentary

“The business environment in China continued to present broad challenges during the third quarter,” commented Chris Sharng, President of Natural Health Trends Corp. “In addition, protests in Hong Kong posed new complications. As a result, we suspended company-sponsored meetings in Hong Kong as current conditions are not conducive to hosting visitors.”

Mr. Sharng further commented, “Beyond the elements that are not within our control, we remain pleased with our leaders’ abilities to adapt our business strategy and to continue performing under these circumstances. Subsequent to quarter end, we held a successful event in Macau which was traditionally held during the third quarter. Our fourth quarter order volume trends are already improving following this major event which is a promising development. Lastly, in light of the current business environment, we are implementing cost reduction measures to focus resources on our members and markets. We expect to realize an annualized $5.7 million in savings by the first quarter of 2020.”

Balance Sheet and Cash Flow

Net cash used in operating activities was $3.7 million compared to net cash provided by operating activities of $8.8 million in the third quarter of 2018. For the first nine months of 2019, net cash used in operating activities was $18.7 million, compared to net cash provided by operating activities of $25.3 million in the first nine months of 2018.
Total cash and cash equivalents were $101.1 million as of September 30, 2019, down from $132.7 million as of December 31, 2018.
On October 29, 2019, the Company’s Board of Directors declared a special cash dividend of $0.40 per share on outstanding common stock. The dividend will be payable on November 29, 2019 to stockholders of record as of November 19, 2019.
During the three months ended September 30, 2019, the Company purchased a total of 383,127 shares of its common stock for an aggregate purchase price of $2.9 million, plus transaction costs. As of September 30, 2019, $22.4 million of the stock repurchase program remained available for future purchases, inclusive of related estimated income tax.

Third Quarter 2019 Financial Results Conference Call

Management will host a conference call to discuss the third quarter 2019 financial results today, Friday November 1, 2019 at 11:30 a.m. Eastern Time. The conference call details are as follows:
Date:
Friday, November 1, 2019
Time:
11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time
Dial-in:
1-877-407-0789 (Domestic)
1-201-689-8562 (International)
Conference ID:
13695076
Webcast:
http://public.viavid.com/index.php?id=136315
For those unable to participate during the live broadcast, a replay of the call will also be available from 2:30 p.m. Eastern Time on November 1, 2019 through 11:59 p.m. Eastern Time on November 15, 2019 by

2



dialing 1-844-512-2921 (domestic) and 1-412-317-6671 (international) and referencing the replay pin number: 13695076.

About Natural Health Trends Corp.

Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.

Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on April 26, 2019 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

CONTACTS:

Company Contact:
Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (Hong Kong): +852-3107-0800
Tel (U.S.): 310-541-0888
scott.davidson@nhtglobal.com
         
Investor Contact:
ADDO Investor Relations
Tel: 310-829-5400
investor.relations@nhtglobal.com

3



NATURAL HEALTH TRENDS CORP.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data) 

 
September 30, 2019
 
December 31, 2018
 
(Unaudited)
 
 
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
101,113

 
$
132,653

Inventories
7,999

 
12,165

Other current assets
6,997

 
5,369

Total current assets
116,109

 
150,187

Property and equipment, net
821

 
934

Operating lease right-of-use assets
3,515

 

Goodwill
1,764

 
1,764

Restricted cash
2,881

 
2,998

Deferred tax asset
1,210

 
1,207

Other assets
807

 
831

Total assets
$
127,107

 
$
157,921

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
627

 
$
1,631

Accrued commissions
3,798

 
12,502

Other accrued expenses
3,392

 
6,121

Deferred revenue
3,302

 
6,795

Amounts held in eWallets
13,090

 
14,611

Operating lease liabilities
1,689

 

Other current liabilities
1,188

 
1,424

Total current liabilities
27,086

 
43,084

Income taxes payable
15,365

 
16,982

Deferred tax liability
186

 
186

Long-term incentive

 
7,808

Operating lease liabilities
1,903

 

Total liabilities
44,540

 
68,060

Stockholders’ equity:
 
 
 
Preferred stock

 

Common stock
13

 
13

Additional paid-in capital
86,102

 
86,415

Retained earnings
23,567

 
44,431

Accumulated other comprehensive loss
(1,764
)
 
(1,250
)
Treasury stock, at cost
(25,351
)
 
(39,748
)
Total stockholders’ equity
82,567

 
89,861

Total liabilities and stockholders’ equity
$
127,107

 
$
157,921



4



NATURAL HEALTH TRENDS CORP. 
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands, except per share data)
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2019
 
2018
 
2019
 
2018
Net sales
$
17,023

 
$
47,043

 
$
59,779

 
$
150,320

Cost of sales
4,371

 
9,926

 
15,002

 
30,546

Gross profit
12,652

 
37,117

 
44,777

 
119,774

Operating expenses:
 
 
 
 
 
 
 
Commissions expense
7,362

 
22,001

 
28,258

 
67,291

Selling, general and administrative expenses
6,354

 
7,269

 
20,296

 
24,484

Total operating expenses
13,716

 
29,270

 
48,554

 
91,775

Income (loss) from operations
(1,064
)
 
7,847

 
(3,777
)
 
27,999

Other income, net
323

 
249

 
1,128

 
465

Income (loss) before income taxes
(741
)
 
8,096

 
(2,649
)
 
28,464

Income tax provision
502

 
467

 
120

 
2,988

Net income (loss)
$
(1,243
)
 
$
7,629

 
$
(2,769
)
 
$
25,476

Net income (loss) per common share:
 
 
 
 
 
 
 
Basic
$
(0.12
)
 
$
0.67

 
$
(0.25
)
 
$
2.25

Diluted
$
(0.12
)
 
$
0.67

 
$
(0.25
)
 
$
2.25

Weighted-average number of common shares outstanding:
 
 
 
 
 
 
 
Basic
10,623

 
11,309

 
11,010

 
11,298

Diluted
10,623

 
11,322

 
11,010

 
11,307



5



NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
 
 
Nine Months Ended September 30,
 
2019
 
2018
CASH FLOWS FROM OPERATING ACTIVITIES:
 
 
 
Net income (loss)
$
(2,769
)
 
$
25,476

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
 
 
 
Depreciation and amortization
290

 
332

Noncash lease expense
1,336

 

Deferred income taxes
(3
)
 

Changes in assets and liabilities:
 
 
 
Inventories
4,104

 
(2,828
)
Other current assets
(1,674
)
 
2,548

Other assets
2

 
(83
)
Accounts payable
(1,002
)
 
967

Accrued commissions
(8,683
)
 
2,003

Other accrued expenses
(1,779
)
 
314

Deferred revenue
(3,485
)
 
26

Amounts held in eWallets
(1,508
)
 
(930
)
Operating lease liabilities
(1,392
)
 

Income taxes payable
(1,617
)
 
(2,201
)
Other current liabilities
(235
)
 
438

Long-term incentive
(333
)
 
(800
)
Net cash provided by (used in) operating activities
(18,748
)
 
25,262

CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
Purchases of property and equipment
(181
)
 
(176
)
Net cash used in investing activities
(181
)
 
(176
)
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
Repurchase of common stock
(9,564
)
 

Dividends paid
(2,736
)
 
(27,644
)
Net cash used in financing activities
(12,300
)
 
(27,644
)
Effect of exchange rates on cash, cash equivalents and restricted cash
(428
)
 
(711
)
Net decrease in cash, cash equivalents and restricted cash
(31,657
)
 
(3,269
)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period
135,651

 
138,478

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period
$
103,994

 
$
135,209

SUPPLEMENTAL DISCLOSURES OF OTHER CASH FLOW INFORMATION:
 
 
 
Issuance of treasury stock for employee awards, net
$
8,289

 
$
554

Right-of-use assets obtained in exchange for operating lease liabilities
$
5,058

 
$



6

EX-101.SCH 3 nhtc-20191101.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001000 - Document - Cover page link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 nhtc-20191101_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 nhtc-20191101_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 nhtc-20191101_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover page. Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, Address Line Three Entity Address, City or Town Entity Address, City or Town Entity Address, Country Entity Address, Country City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag EX-101.PRE 7 nhtc-20191101_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 8 nhtc20191101_8k_htm.xml IDEA: XBRL DOCUMENT 0000912061 2019-11-01 2019-11-01 false 0000912061 8-K 2019-11-01 NATURAL HEALTH TRENDS CORP. DE 001-36849 59-2705336 Units 1205-07, 12F Mira Place Tower A 132 Nathan Road Tsimshatsui HK 852 3107-0800 false false false false Common Stock, par value $0.001 per share NHTC NASDAQ false XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Cover page
Nov. 01, 2019
Cover page.  
Document Type 8-K
Document Period End Date Nov. 01, 2019
Entity Registrant Name NATURAL HEALTH TRENDS CORP.
Entity Incorporation, State or Country Code DE
Entity File Number 001-36849
Entity Tax Identification Number 59-2705336
Entity Address, Address Line One Units 1205-07, 12F
Entity Address, Address Line Two Mira Place Tower A
Entity Address, Address Line Three 132 Nathan Road
Entity Address, City or Town Tsimshatsui
Entity Address, Country HK
City Area Code 852
Local Phone Number 3107-0800
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol NHTC
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0000912061
Amendment Flag false
JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nhtc20191101_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "nhtc-20191101_cal.xml" ] }, "definitionLink": { "local": [ "nhtc-20191101_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "nhtc20191101_8k.htm" ] }, "labelLink": { "local": [ "nhtc-20191101_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "nhtc-20191101_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "nhtc-20191101.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nhtc", "nsuri": "http://www.naturalhealthtrendscorp.com/20191101", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nhtc20191101_8k.htm", "contextRef": "D2019Q3ER", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Cover page", "role": "http://www.naturalhealthtrendscorp.com/role/CoverPage", "shortName": "Cover page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nhtc20191101_8k.htm", "contextRef": "D2019Q3ER", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "countryCodeItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 14 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 1 97 1 false 0 0 false 0 false false R1.htm 0001000 - Document - Cover page Sheet http://www.naturalhealthtrendscorp.com/role/CoverPage Cover page Cover 1 false false All Reports Book All Reports nhtc20191101_8k.htm ex99-1.htm nhtc-20191101.xsd nhtc-20191101_cal.xml nhtc-20191101_def.xml nhtc-20191101_lab.xml nhtc-20191101_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true EXCEL 16 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end ZIP 17 0000912061-19-000080-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000912061-19-000080-xbrl.zip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end